In 2017, 280 000 doses of influenza vaccine containing similar strains of viruses as that in 2016/2017, are being procured.
The composition of this year’s vaccine will correspond to WHO recommendations for this season.
The strains in this year’s flu vaccine, Influvac 2017/2018, are as follows:
- A/Michigan/45/2015 (H1N1)pdm09-similar strain (A/Singapore/GP1908/2015, IVR-180)
- A/Hong Kong/4801/2014 (H3N2)-similar strain (A/Hong Kong/4801/2014, NYMC X-263B)
- B/Brisbane/60/2008-similar strain (B/Brisbane/60/2008, wild type)
Vaccination is recommended and free of charge for:
- persons aged 65 and over
- residents of care and chronic care homes (regardless of age, including children)
- patients with chronic diseases, especially diseases of the heart and lungs, including children, and those with impaired lung function and congenital abnormalities in particular
- adults and children with chronic diseases of metabolism, chronic kidney disease, hemoglobinopathies and immune system deficiency
children and adolescents (6 months to 18 years) on long-term therapy with drugs containing acetylsalicylic acid
- close contacts (e.g. house contacts, including children, providers of home health care etc.) of persons who, despite recommendation, cannot have the flu vaccine (contraindication)
- residential care and chronic care home employees
- pregnant women in the second half of pregnancy with any of the above chronic conditions
You will be able to have your flu shot at your GP’s or at public health institutes.
Information on the beginning of this year’s flu immunisation programme will be available on our website and in media.